Amber C. Donahue

1.3k total citations
22 papers, 583 citations indexed

About

Amber C. Donahue is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Amber C. Donahue has authored 22 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Amber C. Donahue's work include Chronic Lymphocytic Leukemia Research (8 papers), Acute Myeloid Leukemia Research (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Amber C. Donahue is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Acute Myeloid Leukemia Research (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Amber C. Donahue collaborates with scholars based in United States, United Kingdom and Japan. Amber C. Donahue's co-authors include David A. Fruman, Eric Sariban, Ian Magrath, Chen-Hsiung Yeh, Owen N. Witte, Anne B. Satterthwaite, Gregory Z. Ferl, Jay G. Wohlgemuth, J.K. Brunso-Bechtold and Hagop M. Kantarjian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Amber C. Donahue

22 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amber C. Donahue United States 14 286 215 130 122 92 22 583
Marit E. Hystad Norway 14 328 1.1× 120 0.6× 134 1.0× 76 0.6× 83 0.9× 19 640
Maxim Kebenko Germany 12 243 0.8× 165 0.8× 265 2.0× 62 0.5× 135 1.5× 30 609
D L Boyle United States 11 154 0.5× 234 1.1× 152 1.2× 93 0.8× 99 1.1× 11 713
Lynett Danks United Kingdom 9 278 1.0× 352 1.6× 166 1.3× 53 0.4× 43 0.5× 9 710
Veronica Martini Italy 19 281 1.0× 315 1.5× 150 1.2× 308 2.5× 102 1.1× 41 740
M Schena Italy 17 245 0.9× 277 1.3× 225 1.7× 287 2.4× 114 1.2× 34 893
Patrik Georgii‐Hemming Sweden 14 409 1.4× 133 0.6× 244 1.9× 68 0.6× 233 2.5× 17 778
Dorian LaTocha United States 13 238 0.8× 261 1.2× 87 0.7× 199 1.6× 190 2.1× 19 663
Sylwia Chocholska Poland 17 221 0.8× 231 1.1× 220 1.7× 238 2.0× 138 1.5× 55 692
Chantal Humblet Belgium 13 149 0.5× 183 0.9× 132 1.0× 51 0.4× 66 0.7× 35 460

Countries citing papers authored by Amber C. Donahue

Since Specialization
Citations

This map shows the geographic impact of Amber C. Donahue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber C. Donahue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber C. Donahue more than expected).

Fields of papers citing papers by Amber C. Donahue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amber C. Donahue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber C. Donahue. The network helps show where Amber C. Donahue may publish in the future.

Co-authorship network of co-authors of Amber C. Donahue

This figure shows the co-authorship network connecting the top 25 collaborators of Amber C. Donahue. A scholar is included among the top collaborators of Amber C. Donahue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amber C. Donahue. Amber C. Donahue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choueiri, Toni K., Amber C. Donahue, David A. Braun, et al.. (2023). Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell Carcinoma. Cancer Discovery. 14(3). 406–423. 6 indexed citations
2.
Pujade-Lauraine, Éric, Jonathan A. Ledermann, Amit M. Oza, et al.. (2021). 229 Avelumab combined with pegylated liposomal doxorubicin in platinum-resistant/refractory ovarian cancer: biomarker analyses from JAVELIN Ovarian 200. A210.2–A211. 1 indexed citations
3.
Pujade-Lauraine, Éric, Jonathan A. Ledermann, Amit M. Oza, et al.. (2021). 225 Avelumab alone in platinum-resistant/refractory ovarian cancer: selected biomarker analyses from the JAVELIN Ovarian 200 trial. A210.1–A210. 1 indexed citations
4.
Choueiri, Toni K., Amber C. Donahue, Brian I. Rini, et al.. (2021). Integrating peripheral biomarker analyses from JAVELIN Renal 101: Avelumab + axitinib (A + Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC).. Journal of Clinical Oncology. 39(15_suppl). 4547–4547. 1 indexed citations
5.
Donahue, Amber C., et al.. (2011). Multiplex ligation-dependent probe amplification for detection of chromosomal abnormalities in myelodysplastic syndrome and acute myeloid leukemia. Leukemia Research. 35(11). 1477–1483. 16 indexed citations
6.
Ma, Wanlong, Hagop M. Kantarjian, Ke Zhang, et al.. (2010). Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome. BMC Medical Genetics. 11(1). 163–163. 15 indexed citations
7.
Bruey, Jean-Marie, Hagop M. Kantarjian, Wanlong Ma, et al.. (2010). Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia. Leukemia Research. 34(10). 1320–1324. 11 indexed citations
8.
9.
Ma, Wanlong, Hagop M. Kantarjian, B. Nebiyou Bekele, et al.. (2009). Proteasome Enzymatic Activities in Plasma as Risk Stratification of Patients with Acute Myeloid Leukemia and Advanced-Stage Myelodysplastic Syndrome. Clinical Cancer Research. 15(11). 3820–3826. 40 indexed citations
10.
Sonntag, William E., et al.. (2009). Early-onset GH deficiency results in spatial memory impairment in mid-life and is prevented by GH supplementation. Journal of Endocrinology. 204(1). 31–36. 55 indexed citations
11.
Albitar, Maher, Steven J. Potts, Francis J. Giles, et al.. (2009). Proteomics-based prediction of clinical response in acute myeloid leukemia. Experimental Hematology. 37(7). 784–790. 11 indexed citations
12.
Ma, Wanlong, Hagop M. Kantarjian, Xi Zhang, et al.. (2009). Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: Clinical significance and implications. Cancer Biomarkers. 5(1). 51–58. 12 indexed citations
13.
Donahue, Amber C., et al.. (2007). Measuring Phosphorylated Akt and Other Phosphoinositide 3-kinase-Regulated Phosphoproteins in Primary Lymphocytes. Methods in enzymology on CD-ROM/Methods in enzymology. 434. 131–154. 14 indexed citations
14.
Donahue, Amber C. & David A. Fruman. (2007). Distinct signaling mechanisms activate the target of rapamycin in response to different B‐cell stimuli. European Journal of Immunology. 37(10). 2923–2936. 62 indexed citations
15.
Hess, Kristen L., et al.. (2004). Frontline: The p85α isoform of phosphoinositide 3‐kinase is essential for a subset of B cell receptor‐initiated signaling responses. European Journal of Immunology. 34(11). 2968–2976. 17 indexed citations
16.
Donahue, Amber C.. (2004). Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85 . International Immunology. 16(12). 1789–1798. 27 indexed citations
17.
Donahue, Amber C., et al.. (2004). PI3K signaling controls cell fate at many points in B lymphocyte development and activation. Seminars in Cell and Developmental Biology. 15(2). 183–197. 52 indexed citations
18.
Donahue, Amber C., et al.. (2003). Proliferation and Survival of Activated B Cells Requires Sustained Antigen Receptor Engagement and Phosphoinositide 3-Kinase Activation. The Journal of Immunology. 170(12). 5851–5860. 80 indexed citations
19.
Ferl, Gregory Z., et al.. (2001). Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes. Proceedings of the National Academy of Sciences. 99(1). 359–364. 59 indexed citations
20.
Sariban, Eric, Amber C. Donahue, & Ian Magrath. (1984). Jaw involvement in American Burkitt's lymphoma. Cancer. 53(8). 1777–1782. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marit E. Hystad Breakdown of academic impact, for papers by Maxim Kebenko Breakdown of academic impact, for papers by D L Boyle Breakdown of academic impact, for papers by Lynett Danks Breakdown of academic impact, for papers by Veronica Martini Breakdown of academic impact, for papers by M Schena Breakdown of academic impact, for papers by Patrik Georgii‐Hemming Breakdown of academic impact, for papers by Dorian LaTocha Breakdown of academic impact, for papers by Sylwia Chocholska Breakdown of academic impact, for papers by Chantal Humblet
Rankless by CCL
2026